| Urokinase and AT-III concentrate treatment in inferior vena cava thrombosis associated with nephrotic syndrome. | |
| | |
MedLine Citation:
|
PMID: 2133253 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
A patient with an inferior vena cava thrombosis in nephrotic syndrome was treated with heparin, AT-III concentrates and urokinase. After a few days on treatment he showed a complete resolution of the thrombosis. We suggest that this therapeutic combination may be a good approach to the treatment of thrombosis in nephrotic syndrome. |
| | |
Authors:
|
S Storti; L Pagano; R Marra; A Grilli; G Falappa; A M De Gaetano; A M Ferrante; B Bizzi |
Related Documents
:
|
3433283 - Histologic studies on the nephrotic syndrome in the elderly. 8072253 - Kidney in galloway-mowat syndrome: clinical spectrum with description of pathology. 6131703 - General anesthesia after neuroleptic malignant syndrome. |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis Volume: 1 ISSN: 0957-5235 ISO Abbreviation: Blood Coagul. Fibrinolysis Publication Date: 1990 Dec |
Date Detail:
|
Created Date: 1992-03-11 Completed Date: 1992-03-11 Revised Date: 2008-11-21 |
Medline Journal Info:
|
Nlm Unique ID: 9102551 Medline TA: Blood Coagul Fibrinolysis Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 743-5 Citation Subset: IM |
Affiliation:
|
Università Cattolica del Sacro Cuore, Rome, Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Antithrombin III / therapeutic use* Humans Kidney Failure, Acute / complications Male Nephrotic Syndrome / complications* Pulmonary Embolism / chemically induced Thrombolytic Therapy* / adverse effects Thrombosis / drug therapy*, etiology Urokinase-Type Plasminogen Activator / adverse effects, therapeutic use* Vena Cava, Inferior* |
| Chemical | |
Reg. No./Substance:
|
9000-94-6/Antithrombin III; EC 3.4.21.73/Urokinase-Type Plasminogen Activator |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Tyrosine kinase blockers: new platelet activation inhibitors.
Next Document: Pelvic haemophilic pseudotumour occurring in a patient with mild haemophilia: a brief report.